Scottish Biotech Secures Millions in Commercialization Investment Funds

Scottish biotech engineering company, uFraction8, has successfully secured more than £2.5 million ($3.3 million) in new investment, which it will use to expand its facilities, grow its team, scale its technology, and deploy large-scale tests with prospective customers.

According to a Jan. 24, 2022 press release, the company, which was founded in 2017, has been building its global profile, progressing from lab-scale prototype to a mini-industrial demonstrator used for customer trials.The company opened a fully owned subsidiary in Poznan, Poland in 2019, which was the recipient of a grant from the National Centre for Research and Development in Poland in 2021. Following this grant, the Polish subsidiary opened new facilities and employed a team of designers and engineers to advance uFraction8’s technology development.

“The bio-manufacturing revolution still requires enabling technologies to deliver its full potential to improve downstream processing optimization in areas like precision fermentation, cell-based approaches, or micro-algae platforms,” said Abel Rossignol, investment director at Thia Ventures (a leading investor in the latest financing round), in the press release. “We believe uFraction8’s technology has the potential to deliver these much-needed improvements at a viable scale.”

“We are excited about this successful investment round and the new partners supporting our mission to produce the best-ever microscale liquid-solid separation systems,” added Brian Miller, co-founder of uFraction8, in the press release.

“This significant investment, along with the immense and highly successful bio-manufacturing sector track record of our new partners, will enable uFraction8 to grow faster than ever before. Our entire team is excited and ready for the hard work ahead in taking the business to the next level and beyond,” said Monika Tomecka, uFraction8 co-founder, in the press release. “We remain open to further collaboration opportunities that will support our aim of promoting our cutting-edge technology across global markets.”

Source: uFraction8